123. Type 3 Diabetes and Brain Health – What you Need to Know
Dr. Suzanne de la Monte, MD, is the leading expert in Type 3 Diabetes related to “Brain Insulin Resistance and Deficiency in Amyloid-Related Neurodegeneration in Alzheimer’s Disease. Listen to her interview on clinical and experimental data linking chronic hyperinsulinaemia to cognitive impairment and neurodegeneration. These experimental and lifestyle trend data suggest chronic low-level nitrosamine exposures are responsible. Dr. de la Monte will share opportunities to discover and implement new treatments and devise preventive measures.
Planned with the Committee for Lifelong Learning
- Describe the characteristics, symptoms and diagnosis of Type 3 Diabetes
- Identify the hypothesis and research in the development and treatment of Type 3 Diabetes
- Summarize the current medical nutrition therapy implications of Type 3 Diabetes
Learning Need Codes:
- 5190 Diabetes Mellitus
- 5300 Neurological: stroke, Alzheimer’s, dementia, Parkinson’s, spinal cord injuries
- 4040 Disease Prevention
- 8.1.5 Applies medical nutrition therapy in disease prevention and management.
- 8.3.6 Keeps abreast of current nutrition and dietetics knowledge and trends.
- 8.1.4 Demonstrates knowledge of nutrient requirements throughout the life span and their role in health promotion and disease management.
Mindy Hermann, MBA, RDN
Suzanne De la Monte, MD, MPH
Professor of Pathology (Neuropathology); Professor of Neurology, Neurosurgery & Medicine; Chief of Pathology & Laboratory Medicine
Warren Alpert Medical School of Brown University ; Rhode Island Hospital and Lifespan Academic Institutions; Providence VA Medical Center